Effectiveness and Safety of CGRP-Targeted Therapies Combined with Lifestyle Modifications for Chronic Migraine in Korean Pediatric Patients: A Retrospective Study
Brain Sciences · 08.05.2025 · 15 (5) · 493
DOI: 10.3390/brainsci15050493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 08.05.2025. Verfasst von Ji-Hoon Na und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 135-720, Republic of Korea. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Pediatric chronic migraine (CM) is a debilitating condition with challenging management due to diagnostic complexities and a lack of evidence-based treatment. Calcitonin gene-related peptide (CGRP)-targeted therapies have transformed adult CM management, but their use in pediatric populations is underexplored. This study evaluated the safety and efficacy of CGRP-targeted therapies combined with structured lifestyle modifications in Korean pediatric patients with CM.
Methods
This retrospective study examined 10 pediatric CM patients treated at Gangnam Severance Hospital from 2021 to 2024. Inclusion criteria were as follows: (1) Pediatric Migraine Disability Assessment Scale (PedMIDAS) score ≥ 30, (2) >2 failed preventive therapies, and (3) ≥8 migraine days per month. Patients received CGRP monoclonal antibodies or antagonists, alongside sleep, dietary, and exercise interventions. Changes in migraine burden, neuropsychological outcomes, and adherence to lifestyle interventions were assessed over 12 months.
Results
Migraine frequency significantly decreased from a median of 26.5 to 14 days per month (p < 0.001); PedMIDAS scores declined from 58.5 to 48.0 (p = 0.037); and acute analgesic use was reduced from 14 to 5 days per month (p < 0.001). Adherence to lifestyle interventions improved significantly (p < 0.001). No serious adverse events were reported, and minor side effects, such as injection site pain and dizziness, were self-limiting.
Conclusions
CGRP-targeted therapies, combined with structured lifestyle modifications, safely and effectively reduce migraine burden in pediatric CM patients. These therapies have facilitated sustainable improvements in management and support their integration into comprehensive pediatric CM care. This study highlights the importance of integrating pharmacologic and lifestyle-based approaches for holistic pediatric migraine management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 135-720, Republic of Korea.
ORCID-Profile: Ji-Hoon Na, Hyunjoo Lee, Young-Mock Lee
Zitieren
APA
Na, J. H., Jeon, H., Shim, J. E., Lee, H., & Lee, Y. M. (2025). Effectiveness and Safety of CGRP-Targeted Therapies Combined with Lifestyle Modifications for Chronic Migraine in Korean Pediatric Patients: A Retrospective Study. Brain Sciences, 15(5), 493. https://doi.org/10.3390/brainsci15050493
Vancouver
Na JH, Jeon H, Shim JE, Lee H, Lee YM. Effectiveness and Safety of CGRP-Targeted Therapies Combined with Lifestyle Modifications for Chronic Migraine in Korean Pediatric Patients: A Retrospective Study. Brain Sciences. 2025;15(5):493. doi:10.3390/brainsci15050493
BibTeX
@article{Na2025,
author = {Na, Ji-Hoon and Jeon, Hayoon and Shim, Ji-Eun and Lee, Hyunjoo and Lee, Young-Mock},
title = {Effectiveness and Safety of CGRP-Targeted Therapies Combined with Lifestyle Modifications for Chronic Migraine in Korean Pediatric Patients: A Retrospective Study},
journal = {Brain Sciences},
year = {2025},
volume = {15},
number = {5},
pages = {493},
doi = {10.3390/brainsci15050493}
}
EUVIMED